Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
… Brian Calingaert Pharmacoepidemiology and Risk Management Headquarters - Research Triangle Park, North … of Epidemiology Analysis in the Pharmacoepidemiology and Risk Management division of RTI-HS. He has experience in data …
… Karanth, DrPH, is a Director in the Health Economics group at RTI-HS. Dr. Karanth is a medical doctor from India … diseases. He is well versed in epidemiological methods, study designs, statistical analyses, health economics and …
… Prevalence of underlying conditions associated with higher risk for severe RSV, influenza, or COVID-19 in adults in the …
… Centers (CMSC) Annual Meeting Share on: Wednesday, June 1 - Sunday, June 5, 2022 Conference Website Research … immunoglobulin levels among B-cell–depleting therapies and risk of infections in relapsing multiple sclerosis. Saidha S, …
… signs and symptoms of respiratory syncytial virus in high-risk adults and immunocompromised populations. Costello J, …
… to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro …
Global Forum for Qualified Persons for Pharmacovigilance (QPPV) Share on: Tuesday, November 8 - Wednesday, November 9, 2022 Event website Alejandro Arana will be presenting an epidemiologist perspective on true adverse reactions in pharma research at the …
… Scientist in the Patient-Centered Outcomes Assessment group with RTI-HS. Dr. Greenblatt has experience in project management, study design, quantitative and qualitative methodologies, …
… is a Director in the Patient-Centered Outcomes Assessment group at RTI-HS. Ms. Kosa has over 20 years of experience in …
… the 2022 American Society of Clinical Psychopharmacology. Risk of mortality associated with Pimavanserin compared with …